← back to search

Wallace Crandall

The Ohio State University · US
Area of research
Genetics · Epidemiology
Research interest
Research focused on Crohn's disease and Disease, with related work in Microbiome, Pathogenesis, Expression quantitative trait loci. Notable publications include 'The Treatment-Naive Microbiome in New-Onset Crohn’s Disease', 'Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study', and 'Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature'.
h-index
citations
5,682
works
20
NIH funding
primary concept
email

Recent publications

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
The Lancet 2024cited by 87position: middledoi
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
Journal of Crohn s and Colitis 2022cited by 36position: middledoi
Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation
Gastroenterology 2019cited by 156position: middledoi
Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease
The American Journal of Gastroenterology 2019cited by 48position: middledoi
Clinical and Genomic Correlates of Neutrophil Reactive Oxygen Species Production in Pediatric Patients With Crohn’s Disease
Gastroenterology 2018cited by 87position: middledoi
Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease
Inflammatory Bowel Diseases 2018cited by 67position: middledoi
The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children
The American Journal of Gastroenterology 2018cited by 47position: middledoi
Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis
Mucosal Immunology 2018cited by 37position: middledoi
Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort
Genes and Immunity 2018cited by 33position: middledoi
Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte–Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn’s Disease
Inflammatory Bowel Diseases 2018cited by 18position: middledoi
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
The Lancet 2017cited by 639position: middledoi
Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease
Nature Genetics 2017cited by 182position: middledoi
Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn’s Disease in Treatment-Naive Pediatric Patients
Gastroenterology 2017cited by 70position: middledoi
Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping
PLoS ONE 2015cited by 36position: middledoi
The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology
Contemporary Clinical Trials 2015cited by 24position: middledoi
Abdominal X‐ray in Pediatric Acute Severe Colitis and Radiographic Predictors of Response to Intravenous Steroids
Journal of Pediatric Gastroenterology and Nutrition 2015cited by 13position: middledoi
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Cell Host & Microbe 2014cited by 3,273position: middledoi
Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature
Journal of Clinical Investigation 2014cited by 526position: middledoi
Effectiveness of Anti-TNFα for Crohn Disease: Research in a Pediatric Learning Health System
PEDIATRICS 2014cited by 36position: middledoi
Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease
Gastroenterology 2013cited by 267position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey S. Hyams · S.P.E.C.I.E.S.6 papers (2014–2022)Anne M. Griffiths · SickKids Foundation6 papers (2014–2022)Robert N. Baldassano · Pennsylvania Hospital5 papers (2014–2019)Lee A. Denson · S.P.E.C.I.E.S.5 papers (2014–2019)Joshua D. Noe · Medical College of Wisconsin4 papers (2014–2019)Subra Kugathasan · Emory University4 papers (2014–2019)Melvin B. Heyman · University of California, San Francisco4 papers (2014–2018)Thomas D. Walters · SickKids Foundation3 papers (2014–2018)David R. Mack · University of Ottawa3 papers (2014–2017)Joel R. Rosh · North Shore Diabetes and Endocrine Associates3 papers (2014–2019)Bruce J. Aronow · The University of Texas Southwestern Medical Center3 papers (2014–2018)Marla C. Dubinsky · Takeda (Japan)2 papers (2017–2019)Susan S. Baker · Hospital for Sick Children2 papers (2014–2017)David J. Keljo · BC Children's Hospital2 papers (2014–2015)Yael Haberman · Medical University of Graz2 papers (2014–2018)Dan Turner · Oxford Nanopore Technologies (United Kingdom)2 papers (2015–2022)Mi‐Ok Kim · Bristol-Myers Squibb (United States)2 papers (2014–2017)James Markowitz · Hospital for Sick Children2 papers (2014–2017)Stephen L. Guthery · University of Utah1 papers (2018–2018)Jeanne Tung · University of Oklahoma Health Sciences Center1 papers (2014–2014)